NanoViricides (NNVC)
NYSE MKT:NNVC

NanoViricides (NNVC) Financial Statements

421 Followers

NanoViricides Financial Overview

NanoViricides's market cap is currently ―. The company's EPS TTM is $-0.81; its P/E ratio is -2.76; NanoViricides is scheduled to report earnings on November 18, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.85M$ -2.10M$ -1.93M$ -3.57M$ -1.70M
EBITDA$ -1.85M$ -1.91M$ -1.74M$ -3.38M$ -1.51M
Net Income Common Stockholders$ -1.85M$ -2.11M$ -1.97M$ -3.58M$ -1.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.26M$ 5.25M$ 6.97M$ 8.15M$ 9.65M
Total Assets$ 11.46M$ 13.40M$ 15.42M$ 16.90M$ 18.58M
Total Debt$ 0.00$ 0.00$ 1.50M$ 1.50M$ 0.00
Net Debt$ -3.26M$ -5.25M$ -5.47M$ -6.65M$ -9.65M
Total Liabilities$ 813.34K$ 951.07K$ 2.45M$ 2.03M$ 348.74K
Stockholders Equity$ 10.65M$ 12.45M$ 12.97M$ 14.87M$ 18.23M
Cash Flow-
Free Cash Flow-$ -1.71M$ -1.21M$ -1.50M$ -1.83M
Operating Cash Flow$ -1.90M$ -1.70M$ -1.20M$ -1.50M$ -1.77M
Investing Cash Flow$ -44.63K$ -5.47K$ -8.29K$ -2.57K$ -59.30K
Financing Cash Flow-----
Currency in USD

NanoViricides Earnings and Revenue History

NanoViricides Debt to Assets

NanoViricides Cash Flow

NanoViricides Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis